Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 20763 / DOSAGE - TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| NARATRIPTAN HYDROCHLORIDE(UNII: 10X8X4P12Z) (NARATRIPTAN - UNII:QX3KXL1ZA2) | NARATRIPTAN | 2.5mg | 1mg |
Inactive Ingredients
| Ingredient Name | GlaxoSmithKline LLC |
|---|---|
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| FD&C BLUE NO. 2(L06K8R7DQK) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| INDIGOTINDISULFONATE SODIUM(D3741U8K7L) | |
| LACTOSE, UNSPECIFIED FORM(J2B2A4N98G) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| TRIACETIN(XHX3C3X673) |
